Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Liabilities and Shareholders Equity: 2020-2025

Historic Liabilities and Shareholders Equity for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to $503.6 million.

  • Beauty Health's Liabilities and Shareholders Equity fell 28.01% to $503.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 25.57%. This contributed to the annual value of $685.7 million for FY2024, which is 26.20% down from last year.
  • Per Beauty Health's latest filing, its Liabilities and Shareholders Equity stood at $503.6 million for Q3 2025, which was down 0.77% from $507.6 million recorded in Q2 2025.
  • Beauty Health's Liabilities and Shareholders Equity's 5-year high stood at $1.2 billion during Q4 2021, with a 5-year trough of $342.5 million in Q2 2021.
  • For the 3-year period, Beauty Health's Liabilities and Shareholders Equity averaged around $775.6 million, with its median value being $711.8 million (2024).
  • In the last 5 years, Beauty Health's Liabilities and Shareholders Equity skyrocketed by 227,928.90% in 2021 and then dropped by 29.34% in 2024.
  • Quarterly analysis of 5 years shows Beauty Health's Liabilities and Shareholders Equity stood at $1.2 billion in 2021, then dropped by 17.70% to $1.0 billion in 2022, then fell by 7.37% to $929.1 million in 2023, then fell by 26.20% to $685.7 million in 2024, then declined by 28.01% to $503.6 million in 2025.
  • Its Liabilities and Shareholders Equity was $503.6 million in Q3 2025, compared to $507.6 million in Q2 2025 and $673.8 million in Q1 2025.